menu
    • menu

    Company profile for Diamond Therapeutics

    NEW Drugs in Dev: 1
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The promise of a new and better class of mental health therapies lies within the chemistry of psychedelic compounds. Our mission is to unlock it. We're developing safe, FDA, EMA and Health Canada approved therapies for neuropsychiatric conditions, starting with sub-perceptual psilocybin-based medicines that have the potential to deliver greater impact than current first-line treatments. Our first clinical program is focused...
    The promise of a new and better class of mental health therapies lies within the chemistry of psychedelic compounds. Our mission is to unlock it. We're developing safe, FDA, EMA and Health Canada approved therapies for neuropsychiatric conditions, starting with sub-perceptual psilocybin-based medicines that have the potential to deliver greater impact than current first-line treatments. Our first clinical program is focused on accessible psilocybin-based drugs that deliver rapid therapeutic outcomes without perceptual side effects. By eliminating the side effects, this intervention can be administered to a broad cohort of patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Diamond TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    Toronto, Ontario CA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.diamondthera.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/diamond-therapeutics/?originalSubdomain=ca
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Black Diamond Therapeutics at Jefferies Global Healthcare Confere
    Black Diamond Therapeutics at Jefferies Global Healthcare Confere

    29 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/29/3090271/0/en/Black-Diamond-Therapeutics-to-Participate-in-Jefferies-Global-Healthcare-Conference.html

    GLOBENEWSWIRE
    29 May 2025
    Share Share
    Black Diamond Therapeutics to Join Investor Conferences
    Black Diamond Therapeutics to Join Investor Conferences

    31 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/31/3052225/0/en/Black-Diamond-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    31 Mar 2025
    Share Share
    First Avenue Ventures Life Science Fund I Invests in Diamond Therapeutics to Accelerate Innovation in Mental Health
    First Avenue Ventures Life Science Fund I Invests in Diamond Therapeutics to Accelerate Innovation in Mental Health

    04 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/first-avenue-ventures-life-science-fund-i-invests-in-diamond-therapeutics-to-accelerate-innovation-in-mental-health-301789555.html

    PR NEWSWIRE
    04 Apr 2023
    Share Share
    Diamond Announces FDA-authorized Clinical Trial of Low-Dose Psilocybin
    Diamond Announces FDA-authorized Clinical Trial of Low-Dose Psilocybin

    21 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/diamond-therapeutics-announces-fda-authorized-clinical-trial-of-low-dose-psilocybin-in-collaboration-with-university-of-alabama-at-birmingham-301776839.html

    PR NEWSWIRE
    21 Mar 2023
    Share Share
    Diamond Therapeutics to give take-home psilocybin doses in Phase II trial
    Diamond Therapeutics to give take-home psilocybin doses in Phase II trial

    15 Feb 2023

    // CLINICAL TRIALS ARENA

    https://www.clinicaltrialsarena.com/news/diamond_therapeutics_phase2_trial/

    CLINICAL TRIALS ARENA
    15 Feb 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search